Browsing: Business

Something unusual is happening in cannabis policy right now. Groups that almost never agree on anything are suddenly speaking the same language. Major medical organizations, Trump-aligned…

The PhilaDelic Fall Forum laid out a roadmap for wider use of ibogaine and mushrooms to treat addiction and depression as stigma fades. Leading chemists, psychiatrists,…

Kentucky’s first medical cannabis dispensary sold out its entire inventory in just seven days, then temporarily closed, a fast start that highlights both intense statewide demand…

High Times officially turned the lights back on July 16, 2025. We didn’t relaunch anything. We reopened the site and started publishing again. And pretty quickly,…

In every country where medical cannabis has been legalized, decisions of this scale don’t happen overnight. They’re shaped by years of pressure, debate, and persistence. In…

For an article in the December, 1979 edition of High Times, late, great counterculture correspondent Glenn O’Brien examined the connections between Santa Claus and a specific…

A Department of Defense (DoD)-funded clinical trial will study MDMA-assisted therapy paired with Massed Prolonged Exposure for PTSD in active-duty service members. For decades, MDMA lived…

President Donald Trump has directed Attorney General Pam Bondi to move quickly on finalizing marijuana’s potential reclassification under federal law, following an executive order signed earlier…

Cannabis didn’t win Trump over with a single argument. It wore him down. For more than a year, executives, advocates, pollsters and old friends circled one…

The ink was barely dry on President Trump’s cannabis rescheduling order when the same question started bouncing around boardrooms, Discords, and trader timelines: Does this mean…